Aravinda Galappatthige

I forget, Mike, if you had given any numbers on adoption there, any targets or any sort of recent adoption numbers that you've quoted

Is it -- correct me if I'm wrong, you bought back $262 million worth of shares as of March 31

I was wondering if it's worthwhile differentiating the position with respect to your customers and larger law firms as opposed to the smaller law firms

Is it fair to sort of characterize the present sort of position as sort of getting close to peak in terms of new product launches

Should we sort of take that forward even in the -- going into '26 that notwithstanding that framework, you have the ability and the willingness to sort of step up

very strong EBITDA growth yet again, similar to what we saw in Q1. Perhaps for Mike, is that predominantly sort of that timing benefit

I was wondering whether you could maybe just revisit the drafting side of the opportunity. I know that you launched the CoCounsel Drafting product last year. Maybe just remind us the TAM there

I was wondering if has there been an uptick as we look at 2025. Or is it pretty much the same run rate